Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD

H. Ekroos, J. Hahl, K. Tuppurainen, K. Linden, M. Linna, H. Sintonen (Porvoo, Espoo, Helsinki, Finland)

Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Ekroos, J. Hahl, K. Tuppurainen, K. Linden, M. Linna, H. Sintonen (Porvoo, Espoo, Helsinki, Finland). Varenicline is a cost-effective pharmacotherapy in smoking cessation of nicotine dependent patients with mild to moderate COPD. Eur Respir J 2012; 40: Suppl. 56, 1294

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Smoking cessation and COPD
Source: Eur Respir Rev 2013; 22: 37-43
Year: 2013



The cost-effectiveness of antidepressants for smoking cessation in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006

Smoking cessation strategies in patients with COPD
Source: Eur Respir J 2013; 41: 727-734
Year: 2013



The effect of bupropion on smoking cessation and sleep physiology in COPD and asthma patients
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

Effects of smoking cessation on spirometry in mild to moderate COPD
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020


Smoking cessation and prevention
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=242
Year: 2006

Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008


The effects of confrontational counselling on smoking cessation in smokers with COPD
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008


Cytisine is an effective smoking cessation medication: more evidence now than ever before
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017

Pharmacological treatment for smoking cessation on COPD smokers
Source: Annual Congress 2011 - PG19 How to set up and deliver a smoking cessation service in a pulmonology department
Year: 2011



Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007




Pharmacological treatment for smoking cessation
Source: Eur Respir Mon; 2008: 42: 74–97
Year: 2008

Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 503s
Year: 2004

Smoking cessation in asthma patients
Source: International Congress 2017 – PG14 Smoking cessation in patients with respiratory diseases
Year: 2017

Still very few smokers are prescribed smoking cessation medications
Source: ISSN=ISSN 1810-6838, ISBN=, page=172
Year: 2005

COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005


Recommendations for smoking cessation treatment in respiratory patients
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007